Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Frontiers in Surgery|July 15, 2022
Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer PatientsShuai Li, Xiaosong Chen, Kunwei Shen
Cancer Communications (London, England)|July 13, 2020
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapyShuning Ding, Xiaosong Chen, Kunwei Shen
Oncotarget|January 7, 2017
Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysisYu Zong, Jiayi Wu, Kunwei Shen
Frontiers in Immunology|March 27, 2023
Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancerBi Lian, Xiaosong Chen, Kunwei Shen
Frontiers in Oncology|December 16, 2024
Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohortShuai Li, Xiaosong Chen, Kunwei Shen
Therapeutic Advances in Drug Safety|March 3, 2025
A post-marketing disproportionality analysis of the safety of ribociclib based on the FDA Adverse Event Reporting SystemJiayan Xu, Ruo Wang, Kunwei Shen
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 15, 2015
[Research progress of tumor infiltrating lymphocytes in breast cancer]Jiahui Huang, Xiaosong Chen, Kunwei Shen
Frontiers in Oncology|November 1, 2021
Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive PatientsJiahui Huang, Yiwei Tong, Xiaosong Chen, et al.
Breast Cancer Research and Treatment|February 29, 2012
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysisXiaosong Chen, Ying Yuan, Zhaoxiang Gu, et al.
Frontiers in Oncology|December 16, 2020
Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer CellsLiang Gao, Kunwei Shen, Ni Yin, et al.
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Frontiers in Surgery|July 15, 2022
Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer PatientsShuai Li, Xiaosong Chen, Kunwei Shen
Cancer Communications (London, England)|July 13, 2020
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapyShuning Ding, Xiaosong Chen, Kunwei Shen
Oncotarget|January 7, 2017
Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysisYu Zong, Jiayi Wu, Kunwei Shen
Frontiers in Immunology|March 27, 2023
Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancerBi Lian, Xiaosong Chen, Kunwei Shen
Frontiers in Oncology|December 16, 2024
Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohortShuai Li, Xiaosong Chen, Kunwei Shen
Therapeutic Advances in Drug Safety|March 3, 2025
A post-marketing disproportionality analysis of the safety of ribociclib based on the FDA Adverse Event Reporting SystemJiayan Xu, Ruo Wang, Kunwei Shen
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 15, 2015
[Research progress of tumor infiltrating lymphocytes in breast cancer]Jiahui Huang, Xiaosong Chen, Kunwei Shen
Frontiers in Oncology|November 1, 2021
Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive PatientsJiahui Huang, Yiwei Tong, Xiaosong Chen, et al.
Breast Cancer Research and Treatment|February 29, 2012
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysisXiaosong Chen, Ying Yuan, Zhaoxiang Gu, et al.
Frontiers in Oncology|December 16, 2020
Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer CellsLiang Gao, Kunwei Shen, Ni Yin, et al.
Pageof 21